Académique Documents
Professionnel Documents
Culture Documents
11
0022-538X/89/114932-06$02.00/0
Copyright C) 1989, American Society for Microbiology
PA21, a strain of hepatitis A virus (HAV) recovered from a naturally infected captive owl monkey, is
indistinguishable from human HAV in polyclonal radioimmunoassays and cross-neutralization studies.
However, cDNA-RNA hybridization has suggested a significant difference at the genomic level between PA21
and a reference human virus, HM175. Further characterization of this unique HAV was undertaken in an
effort to determine the extent of genetic divergence from human HAV and its relation to the conserved antigenic
structure of the virus. The close similarity between PA21 and HM175 antigens was confirmed with an extended
panel of 18 neutralizing murine monoclonal antibodies: a reproducible difference in binding to the two viruses
was detected with only one antibody (B5-B3). The nucleotide sequence of the P1 region of the PA21 genome had
only 83.2% identity with HM175 virus, a difference approximately twice as great as that found between any two
human strains. Most nucleotide changes were in third base positions, and the amino acid sequences of the
capsid proteins were largely conserved. Amino acid replacements were clustered in the carboxy terminus of
VP1 and the amino-terminal regions of VP2 and VP1. These data indicate that PA21 virus represents a unique
genotype of HAV and suggest the existence of an ecologically isolated niche for HAV among feral owl monkeys.
Hepatitis A virus (HAV) is a uniquely pathogenic hepato- most wild-caught animals seroconverting within months of
tropic picornavirus associated with acute viral hepatitis in capture. Virus recovered from infected monkeys was found
humans (17). Infection with HAV results in solid, lifelong to be antigenically similar to human HAV by quantitative in
immunity, due in part to the absence of antigenic variation vitro neutralization assays (19), in cross protection studies,
among HAV isolates. Although direct comparisons are lim- and in preliminary studies with monoclonal antibodies (20).
ited in number, human HAV strains are antigenically indis- Yet slot blot cDNA-RNA hybridization with probes derived
tinguishable from each other in solid-phase immunoassays from human HAV suggested that the PA21 virus was distinct
and neutralization tests employing either convalescent hu- from human HAV isolates (20). We now report the further
man polyclonal antibodies (18, 22) or murine monoclonal characterization of PA21 virus, undertaken in an effort to
antibodies (20). At the genomic level, the nucleotide se- determine the basis of its genetic diversity and how this
quences of these viruses have been estimated by T1 oligo- might relate to its highly conserved antigenic structure.
nucleotide mapping to differ by only 1 to 4% (38), while a PA21 virus was adapted to growth in continuous green
comparison of cDNA sequences derived from several human monkey kidney cells (BS-C-1) as described previously (2).
HAV isolates indicates a 3 to 9% difference (5, 23, 25, 29, 32, The physical characteristics of PA21 particles produced in
36; J. Ticehurst, personal communication). Thus, existing BS-C-1 cells were compared with those of the prototype
human isolates of HAV represent a relatively homogeneous human HAV strain, HM175, propagated in the same cell
collection of closely related viruses, having as a group line. Centrifugation of both PA21 and HM175 virus harvests
significantly less genetic diversity than that found among through linear rate-zonal sucrose gradients demonstrated
isolates of single poliovirus serotypes (31). similar sedimentation profiles, with two major peaks of
Most previous studies have suggested that natural infec- antigen activity having sedimentation characteristics corre-
tion with HAV is confined to humans (8). However, a variety sponding to empty and full capsids (Fig. 1) (21, 34). The
of higher primate species, including chimpanzees (Pan tro- PA21 antigen was distributed almost equally between the
glodytes) (13), marmosets (Saguinas sp.) (9), and owl mon- two particle types, while approximately threefold more
keys (Aotus trivirgatus) (16), have been shown to be suscep- HM175 antigen was associated with complete virions than
tible to infection. Serologic evidence of infection with HAV with empty capsids. This difference in the distribution of
has been found among primates held in captivity (12), but antigen was constant for multiple purifications of both viral
such infection generally has been considered to be of human strains. Fractions recovered from these gradients were blot-
origin (8, 28). HAV appears capable of bidirectional trans- ted onto nitrocellulose and hybridized with the pHAVCH119-
mission between captive primates and their human keepers, 1 probe (representing nucleotides 158 to 843 of the HM175
although the ultimate origin of virus causing hepatitis A in genome). The resulting hybridization signal was strongest
animal handlers has never been entirely clear. with fractions containing complete virus particles, but
'In 1980, an HAV strain (PA21) was recovered from a feral weaker hybridization signals were found with fractions tail-
owl monkey shortly after its capture and admission to a ing into the empty-capsid region of the gradient (Fig. 1). In
primate-holding facility in Panama (22). Serologic testing of both virus-containing gradients, there was a suggestion of a
other owl monkeys demonstrated widespread infection with discrete population of particles yielding positive hybridiza-
HAV within the colony during the preceding years, with tion signals in fractions immediately preceding the empty-
capsid peak (fractions 18 and 19). Thus, with the exception
*
Corresponding author. of proportionately more empty capsids in PA21 virus har-
4932
VOL. 63, 1989 NOTES 4933
TABLE 1. Percent nucleotide identity between PA21 and human HAV isolates
% Nucleotide identity to:
Genomic region
HM175 LA MBB CR326 HAS15 MS1
5' noncoding (bases 456 to 734) 89.2 88.9 89.6 88.6 89.0
P1
VP4'a 92.8 94.2 89.9 92.8 92.8
VP2 83.0 82.7 83.0 82.4 83.5
VP3 84.8 85.5 86.0 85.2 84.7
VP' 81.3 80.0 80.3 80.6 78.4b 80.6
Total (bases 735 to 3107) 83.2 82.9 83.1 82.9 82.lb
P2 2A (bases 3108 to 3661) 79.6 80.1 81.0 80.7
P3 3DP.1 (bases 6879 to 7415) 84.4 82.1 84.2 82.0
3' noncoding (bases 7416 to 7493) 93.7 85.0 85.3 93.2
a Cleavage points between the PA21 capsid proteins were those proposed by Cohen et al. (5) for HM175 virus.
b Includes
18-base deletion in VP1.
VOL. 63, 1989
2208
2928
T-
- - -
-----
-
- -
-
- -
-
-
-
- -
T--T--A--A--A--
V G D D S G G f S t t V S t K 0 N V P D P 0 V G
- -
-- -- -
- - -
-
-
-
-
E - - - - - - - - -
-
-
- - - - - -
- - - - -
-
- -
-
- -
-
- -
-
-- -
- -
-
T---G--T--C-
- - -
-
-
-----
-
-------T--A-----CA----A---T-G-----A-
GTTGGGGATGATTCTGGAGGCTCTCTACCACTGTTTGtTTCCAGACCCTCAAGTTGGCTACAACAGTGAAGTCTAGGtTAGAGCAAAC
- - - - - - - - - --
- - -
-
--
- -
-
--A--A--TC-T--C--T----T--T---A-------A---T-G-----C----A--T-----A----C--A----C--A--G ------G-------
2688 CCCGTTGGGTTAGCAGTAGATACCCCATGGGTTGAGAAGGAGTCTGCTCTTTCTATTGATTACAAGACAGCTCTTGGTGCTGTTAGGTTTAATACTAGAGAA
P V G L A V D t P W V E K E S A L S I D Y K T A L G A V R f N T R R t G N I C I
--^ ^ ^ t T
28M AGGTTGCCCTGGTACTCCTATCT
T^ -T
G T---------
t- -^ - - -TG --
- - -T
- - - - --
- - - --
- - - - - - - -
TTATGCGTCCAGGGGCACGGATGGGCTTGGAGACAAAACAGATTCAATTTGCTT
R L P W Y S Y L Y A V S G A L D G L G D K T D S T f G L V S I 0 I A N Y N H S D
----------------------------------------------
--C
AGCTTCAGATT
-t -- --C-------- -t-
-----K - I-t - - -
---Ct
-
--
-
- - - - - -
GAATTTTGTCTTTTAGTTGTTACTTGTCTGTGACTGAACAGTCTGAGTTTTATTTTCCTAGAGCACCTTTGAATACCATGCTATGATGTCATCAGAACAATGATGGATAGAATTGCT
E Y L S F S C Y L S V t E O S E F Y f P R A P L N T M A N N S S E t N N D R I A
- - - - - - - - S - - - L - t - S --S - - -
FIG. 4. Nucleotide and predicted amino acid sequence of the PA21 capsid protein VP1. Numbering and cleavage sites are based on those
of Cohen et al. (5). The differences present in the HM175 sequence are displayed above (nucleotides) or below (amino acids) the PA21
sequence.
---
- -A-C- ---
-- - - - - - -
T---
- - - - - - -
-
tGTCTCATCAAATTGCAAATTACAATCACTCAGT
-G-
- - -
NOTES
AG----------
-
-
-- --
CCTG
--
- - -
- -
- -
-^
4935
Although it has generally been accepted that captive (North Africa and Australia, respectively) but have identical
primates become infected with HAV by transmission of amino acid sequences. The most striking finding in this
virus from humans, there are several studies that suggest analysis, however, is the distance of PA21 from all other
that HAV infection may occur naturally among some simian strains, even though it was recovered relatively close geo-
species in the wild (3, 6, 35). The identification of PA21 virus graphically to members of the LA-HAS15-CR326 group.
in captive owl monkeys in Panama prompted a serologic A similar analysis was carried out at the 3' end of the viral
analysis of newly captured owl monkeys: 2 of 145 animals genome, adding the recently reported sequence of a strain
were found to have antibody to HAV (22). Similarly, Burke isolated from an old-world cynomolgus monkey (1). The
and Heisey determined that 18 of 54 cynomolgus monkeys nucleotide sequences of the 3' 1,251 bases of the RNA of this
freshly captured at a remote jungle location had anti-HAV
antibodies (3). The prevalence of antibody among these
animals was correlated with weight and thus age, indicating TABLE 2. Percent amino acid identities between capsid proteins
infection in the wild. Others have also found evidence of of HAV strains
infection with HAV in recently captured primates (6, 35). % Amino acid identity to protein of:
Although the possibility that PA21 was acquired from Virus Protein
humans either recently or in the distant past cannot be ruled HM175 LA MBB CR326 HAS15 MS1
out with complete certainty, the substantial differences PA-21 VP4 100.0 95.7 100.0 95.7 95.7
between PA21 and multiple human strains of HAV strongly VP2 97.7 98.2 97.7 96.4 98.2
suggest that this strain is native to the owl monkey. At the VP3 98.4 98.0 98.4 98.0 98.0
nucleotide level, PA21 is almost twice as different from the VP1 95.3 95.3 95.3 95.0 93.3 94.3
human strains as they are from each other. To further assess Total P1 97.1 97.0 97.1 96.3 96.2a
these differences, the University of Wisconsin Genetics
HM175 VP4 95.7 100.0 95.7
Computer Group Sequence Analysis Software Package DIS- VP2 99.1 100.0 97.3 99.1
TANCES program (10) was used to assign quantitative VP3 99.6 100.0 99.6 99.6
measures of the distances between the HAV strains. The VP1 99.3 100.0 99.0 97.Oa 98.3
HAV strains can be placed into two major groups: LA, Total P1 99.2 100.0 98.6 98.3a
HAS15, CR326, HM175, and MBB (the human isolates) and
PA21 (Fig. 6). The human strains can be further divided into LA Total P1 99.2 99.1 99.Oa
two groups. Those that are the most closely related geneti-
cally (LA, HAS15, and CR326) are also the most closely MBB Total P1 98.6 98.3a
related geographically, their origins being California, Ari- CR326 Total P1 98.2a
zona, and Costa Rica, respectively. The other pair, MBB
and HM175, originate from geographically distant areas a
Includes six-amino-acid deletion.
4936 NOTES J. VIROL.
HM175 ,, CR326
LA HAS15
MBB . LA
MBB
CR326 * , ,
HM175
HAS 15
PA21
PA2i
VP4 VP2 VP3 VPI
95 90 85
FIG. 5. Amino acid differences between individual HAV strains Percent Identity
and the consensus human virus sequence in the capsid region. The
consensus sequence at each position was determined by the amino FIG. 6. Relationship among HAV strains according to the capsid
acid present in the majority of the human HAV strains. Each protein nucleotide sequences. The distance along the horizontal
sequence is represented by a horizontal line, with regions encoding lines connecting any pair or group of strains to the first common
capsid proteins marked below this line. Positions where the encoded node denotes the percent nucleotide identity shared by those
amino acid differs from the consensus sequence are shown by marks strains.
above the line.
FEBS Lett. 247:425-428. 21. Lemon, S. M., R. W. Jansen, and J. E. Newbold. 1985. Infec-
2. Binn, L. N., S. M. Lemon, R. H. Marchwicki, R. R. Redfield, tious hepatitis A virus particles produced in cell culture consist
N. L. Gates, and W. H. Bancroft. 1984. Primary isolation and of three distinct types with different buoyant densities in CsCl.
serial passage of hepatitis A virus strains in primate cell cul- J. Virol. 54:78-85.
tures. J. Clin. Microbiol. 20:28-33. 22. Lemon, S. M., J. W. LeDuc, L. N. Binn, A. Escajadillo, and
3. Burke, D. S., and G. B. Heisey. 1984. Wild Malaysian cynomol- K. G. Ishak. 1982. Transmission of hepatitis A virus among
gus monkeys are exposed to hepatitis A virus. Am. J. Trop. recently captured Panamanian owl monkeys. J. Med. Virol.
Med. Hyg. 33:940-944. 10:25-36.
4. Cohen, J. I., B. Rosenblum, J. R. Ticehurst, R. J. Daemer, S. M. 23. Linemeyer, D. L., J. G. Menke, A. Martin-Gallardo, J. V.
Feinstone, and R. H. Purcell. 1987. Complete nucleotide se- Hughes, A. Young, and S. W. Mitra. 1985. Molecular cloning
quence of an attenuated hepatitis A virus: comparison with and partial sequencing of hepatitis A viral cDNA. J. Virol.
wild-type virus. Proc. Natl. Acad. Sci. USA 84:2497-2501. 54:247-255.
5. Cohen, J. I., J. R. Ticehurst, R. H. Purcell, A. Buckler-White, 24. Minor, P. D., M. Ferguson, D. M. A. Evans, J. W. Almond, and
and B. M. Baroudy. 1987. Complete nucleotide sequence of J. P. Icenogle. 1986. Antigenic structure of polioviruses of
wild-type hepatitis A virus: comparison with different strains serotypes 1, 2 and 3. J. Gen. Virol. 67:1283-1291.
of hepatitis A virus and other picornaviruses. J. Virol. 61:50- 25. Najarian, R., D. Caput, W. Gee, S. J. Potter, A. Renard, J.
59. Merryweather, G. Van Nest, and D. Dina. 1985. Primary struc-
6. Coursaget, P., B. Levesque, E. Gretillat, M. Eyraud, L. Ferrara, ture and gene organization of human hepatitis A virus. Proc.
and M. Germain. 1981. Hepatitis A virus in primates outside Natl. Acad. Sci. USA 82:2627-2631.
captivity. Lancet ii:929. 26. Nuesch, J., S. Krech, and G. Siegl. 1988. Detection and charac-
7. de Chastonay, J., and G. Siegl. 1987. Replicative events in terization of subgenomic RNAs in hepatitis A virus particles.
hepatitis A virus-infected MRC-5 cells. Virology 157:268-275. Virology 165:419-427.
8. Deinhardt, F. 1976. Hepatitis in primates. Adv. Virus Res. 27. Palmenberg, A. C. 1989. Sequence alignments of picornaviral
20:113-157. capsid proteins, p. 211-241. In B. Semler and E. Ehrenfeld
9. Deinhardt, F., D. Peterson, G. Cross, L. Wolfe, and A. W. (ed.), Molecular aspects of picornavirus infection and detection.
Holmes. 1975. Hepatitis in marmosets. Am. J. Med. Sci. 270: American Society for Microbiology, Washington, D.C.
73-80. 28. Pattison, C. P., J. E. Maynard, and J. S. Bryan. 1975. Subhuman
10. Devereux, J., P. Haeberli, and 0. Smithies. 1984. A comprehen- primate-associated hepatitis. J. Infect. Dis. 132:478-479.
sive set of sequence analysis programs for the VAX. Nucleic 29. Paul, A. V., H. Tada, K. von der Helm, T. Wissel, R. Kiehn, E.
Acids Res. 12:387-395. Wimmer, and F. Deinhardt. 1987. The entire nucleotide se-
11. Diamond, D. C., E. Wimmer, K. von der Helm, and F. Dein- quence of the genome of human hepatitis A virus (isolate MBB).
hardt. 1986. The genomic map of hepatitis A virus: an alternate Virus Res. 8:153-171.
analysis. Microb. Pathog. 1:217-219. 30. Ping, L.-H., R. W. Jansen, J. T. Stapleton, J. I. Cohen, and
12. Dienstag, J. L., F. M. Davenport, R. W. McCoHlum, A. V. S. M. Lemon. 1988. Identification of an immunodominant anti-
Hennessy, G. Klatskin, and R. H. Purcell. 1976. Nonhuman genic site involving the capsid protein VP3 of hepatitis A virus.
primate-associated viral hepatitis type A: serologic evidence of Proc. Natl. Acad. Sci. USA 85:8281-8285.
hepatitis A virus infection. J. Am. Med. Assoc. 236:462-464. 31. Rico-Hesse, R., M. A. Pallansch, B. K. Nottay, and 0. M. Kew.
13. Dienstag, J. L., S. M. Feinstone, R. H. Purcell, J. H. Hoofnagle, 1987. Geographic distribution of wild poliovirus type 1 geno-
L. F. Barker, W. T. London, H. Popper, J. M. Peterson, and types. Virology 160:311-322.
A. Z. Kapikian. 1975. Experimental infection of chimpanzees 32. Robertson, B. H., V. K. Brown, and D. W. Bradley. 1987.
with hepatitis A virus. J. Infect. Dis. 132:532-545. Nucleic acid sequence of the VP1 region of attenuated MS-1
14. Gubler, U., and B. J. Hoffman. 1983. A simple and very efficient hepatitis A virus. Virus Res. 8:309-316.
method for generating cDNA libraries. Gene 25:263-269. 33. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequenc-
15. Jansen, R. W., J. E. Newbold, and S. M. Lemon. 1988. Complete ing with chain-terminating inhibitors. Proc. Natl. Acad. Sci.
nucleotide sequence of a cell culture-adapted variant of hepatitis USA 74:5463-5467.
A virus: comparison with wild-type virus with restricted capac- 34. Siegl,-G., and G. G. Frosner. 1978. Characterization and classi-
ity for in vitro replication. Virology 163:299-307. fication of virus particles associated with hepatitis A. I. Size,
16. LeDuc, J. W., S. M. Lemon, C. M. Keenan, R. R. Graham, density and sedimentation. J. Virol. 26:40-47.
R. H. Marchwicki, and L. N. Binn. 1983. Experimental infection 35. Smith, M. S., P. J. Swanepoel, and M. Bootsma. 1980. Hepatitis
of the New World owl monkey (Aotus trivirgatus) with hepatitis A in nonhuman primates in nature. Lancet ii:1241-1242.
A virus. Infect. Immun. 40:766-772. 36. Sverdlov, E. D., S. A. Tsarev, S. V. Markova, S. K. Vasilenko,
17. Lemon, S. M. 1985. Type A viral hepatitis: new developments in V. E. Chizhikov, N. A. Petrov, Y. Y. Kusov, T. A. Nastashenko,
an old disease. N. Engl. J. Med. 313:1059-1067. and M. S. Balayan. 1987. Cloning and expression of hepatitis A
18. Lemon, S. M., and L. N. Binn. 1983. Serum neutralizing virus genome in E. coli cells. Mol. Gen. (Life Sci. Adv.)
antibody response to hepatitis A virus. J. Infect. -Dis. 148: 6:129-133.
1033-1039. 37. Ticehurst, J. R., V. R. Racaniello, B. M. Baroudy, D. Baltimore,
19. Lemon, S. M., and L. N. Binn. 1983. Antigenic relatedness of R. H. Purcell, and S. M. Feinstone. 1983. Molecular cloning and
two strains of hepatitis A virus determined by cross-neutraliza- characterization of hepatitis A virus cDNA. Proc. Natl. Acad.
tion. Infect. Immun. 42:418-420. Sci. USA 80:5885-5889.
20. Lemon, S. M., S.-F. Chao, R. W. Jansen, L. N. Binn, and J. W. 38. Weitz, M., and G. Siegl. 1985. Variation among hepatitis A virus
LeDuc. 1987. Genomic heterogeneity among human and nonhu- strains. I. Genomic variation detected by T1 oligonucleotide
man strains of hepatitis A virus. J. Virol. 61:735-742. mapping. Virus Res. 4:53-67.